OverviewChartProfileKey statisticsFinancialsNews
Derivatives
TraderScreen

RECORDATI SPA EO -,125/  IT0003828271  /

TradeGate
2024-07-25  9:05:04 AM Chg. +0.60 Volume Bid9:59:19 PM Ask9:59:19 PM Market Capitalization Dividend Y. P/E Ratio
52.00EUR +1.17% 164
Turnover: 8,499.20		 51.95Bid Size: 110 52.45Ask Size: 100 10.76 bill.EUR 2.30% 27.60
GlobeNewswire 2021-12-20 CENTOGENE Announces CEO to Take Temporary Medical Leave of Absence – Biopharmaceutical Industry Vete...
GlobeNewswire 2021-12-20 Eton Pharmaceuticals and ANI Pharmaceuticals Announce Commercial Availability of Carglumic Acid Tabl...
GlobeNewswire 2021-03-23 RECORDATI: POSITIVE RESULTS FROM THE PHASE III LINC 4 STUDY PRESENTED AT THE ENDOCRINE SOCIETY’S AN...
GlobeNewswire 2021-02-22 RECORDATI: PRELIMINARY 2020 RESULTS CONFIRM CONTINUED GROWTH OF OPERATING INCOME AND NET INCOME. EBI...
GlobeNewswire 2021-01-29 RECORDATI: LICENSE OBTAINED FOR THE COMMERCIALIZATION OF ELIGARD IN EUROPE AND OTHER COUNTRIES
GlobeNewswire 2020-11-30 RECORDATI: MARKET AUTHORIZATION APPLICATION FOR ARS-1 (EPINEPHRINE NASAL SPRAY) ACCEPTED BY EUROPEA...
GlobeNewswire 2020-11-05 Amryt Reports Record Q3 2020 Results - Raising FY 2020 Revenue Guidance
GlobeNewswire 2020-10-29 RECORDATI: PROFIT GROWTH IN THE FIRST NINE MONTHS OF 2020. REVENUES -0.6%, EBITDA +7.1%, ADJUSTED NE...
GlobeNewswire 2020-10-01 RECORDATI: MERGER BY ABSORPTION OF FIMEI S.P.A. AND ROSSINI INVESTIMENTI S.P.A. INTO RECORDATI S.P....
GlobeNewswire 2020-09-21 RECORDATI LICENSES AN INNOVATIVE EPINEPHRINE NASAL SPRAY IN DEVELOPMENT FOR ANAPHYLAXIS PREVENTION
GlobeNewswire 2020-08-06 AMRYT ANNOUNCES Q2 2020 RESULTS AND ISSUES POSITIVE REVENUE GUIDANCE FOR FY 2020
GlobeNewswire 2020-07-30 RECORDATI ANNOUNCES POSITIVE FIRST HALF 2020 RESULTS. REVENUES +2.3%, EBITDA +11.4%, ADJUSTED NET IN...
GlobeNewswire 2020-06-17 RECORDATI: ISTURISA® (OSILODROSTAT) PHASE III LINC-4 TRIAL MEETS ITS PRIMARY ENDPOINT IN CUSHING’S D...
GlobeNewswire 2020-05-14 Eton Pharmaceuticals Announces First Quarter 2020 Financial Results
GlobeNewswire 2020-05-11 Amryt Pharma Plc - Q1 2020 RESULTS
GlobeNewswire 2020-05-11 Amryt Pharma Plc - Full Year 2019 RESULTS
GlobeNewswire 2020-05-07 RECORDATI ANNOUNCES GROWTH IN THE FIRST QUARTER 2020. REVENUES +12.1%, EBITDA +20.1%
GlobeNewswire 2020-05-04 Eton Pharmaceuticals Announces Appointment of Paul Stickler as Senior Vice President of Sales and Ma...
GlobeNewswire 2020-04-29 RECORDATI SHAREHOLDERS APPROVE THE 2019 ACCOUNTS. DIVIDEND € 1.00 PER SHARE (+8.7% vs 2018)
GlobeNewswire 2020-04-08 Recordati Rare Diseases now holds Isturisa® European MA
GlobeNewswire 2020-03-26 RECORDATI SUBMITS NEW DRUG APPLICATION FOR ISTURISA® IN JAPAN
GlobeNewswire 2020-03-18 RECORDATI CONTRIBUTES TO SUPPORT HOSPITALS AND PATIENTS IN THE FACE OF THE EPIDEMIOLOGIC EMERGENCY D...
GlobeNewswire 2020-03-18 BOARD APPROVES THE 2019 ACCOUNTS. SALES € 1,481.8 MILLION (+9.6%), EBITDA € 544.0 MILLION (+9.0%). ...
GlobeNewswire 2020-02-14 RECORDATI: PRELIMINARY 2019 RESULTS CONFIRM CONTINUED GROWTH OF SALES AND PROFITS. SALES +9.6%. EBIT...
GlobeNewswire 2020-01-15 RECORDATI: ISTURISA® (OSILODROSTAT) APPROVED